Michael Rogers
2015 - Acorda Therapeutics
In 2015, Michael Rogers earned a total compensation of $1.4M as Chief Financial Officer former at Acorda Therapeutics, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $194,503 |
|---|---|
| Option Awards | $534,853 |
| Salary | $412,417 |
| Stock Awards | $209,865 |
| Other | $90,044 |
| Total | $1,441,682 |
Rogers received $534.9K in option awards, accounting for 37% of the total pay in 2015.
Rogers also received $194.5K in non-equity incentive plan, $412.4K in salary, $209.9K in stock awards and $90K in other compensation.
Rankings
In 2015, Michael Rogers' compensation ranked 6,192nd out of 13,638 executives tracked by ExecPay. In other words, Rogers earned more than 54.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,192 out of 13,638 | 55th |
Division Manufacturing | 2,319 out of 5,190 | 55th |
Major group Chemicals And Allied Products | 836 out of 1,854 | 55th |
Industry group Drugs | 668 out of 1,528 | 56th |
Industry Biological Products, Except Diagnostic Substances | 114 out of 254 | 55th |
Source: SEC filing on April 21, 2017.
Rogers' colleagues
We found six more compensation records of executives who worked with Michael Rogers at Acorda Therapeutics in 2015.
2015
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2015
Jane Wasman
Acorda Therapeutics
General Counsel
2015
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2015
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2015
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
2015
Andrew Hindman
Acorda Therapeutics